PELLEGATA, NATALIA SIMONA
 Distribuzione geografica
Continente #
NA - Nord America 672
EU - Europa 461
AS - Asia 202
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.337
Nazione #
US - Stati Uniti d'America 662
IE - Irlanda 199
CN - Cina 188
UA - Ucraina 62
IT - Italia 50
FI - Finlandia 42
DE - Germania 39
SE - Svezia 30
GB - Regno Unito 14
FR - Francia 12
CA - Canada 10
BE - Belgio 7
SG - Singapore 6
AT - Austria 4
PK - Pakistan 3
HK - Hong Kong 2
RU - Federazione Russa 2
EU - Europa 1
IL - Israele 1
IR - Iran 1
MU - Mauritius 1
TR - Turchia 1
Totale 1.337
Città #
Dublin 196
Chandler 186
Ashburn 60
Jacksonville 60
Nanjing 55
Lawrence 32
Princeton 32
Medford 30
Wilmington 28
Beijing 19
Hebei 19
Jiaxing 17
Nanchang 17
Milan 16
Boardman 13
Changsha 13
Shenyang 13
Helsinki 12
Shanghai 12
Tianjin 10
Ann Arbor 9
Germering 9
Toronto 9
Seattle 8
Brussels 7
Monza 6
Singapore 6
Verona 6
Pavia 5
Secaucus 5
Falls Church 4
Hangzhou 4
Los Angeles 4
Alessandria 3
Norwalk 3
Vienna 3
Bolzano 2
Cepagatti 2
Des Moines 2
Fairfield 2
Guangzhou 2
Hong Kong 2
Munich 2
New York 2
Washington 2
Woodbridge 2
Ardabil 1
Auburn Hills 1
Blainville 1
Changchun 1
Frankfurt am Main 1
Kemerovo 1
L'aquila 1
Lanzhou 1
Mersin 1
Moscow 1
Phoenix 1
Rehovot 1
Rockville 1
San Francisco 1
Wuppertal 1
Totale 966
Nome #
Analysis and clinical implications of K-ras gene mutations and infection with human papillomavirus types 16 and 18 in primary adenocarcinoma of the uterine cervix 72
Effects of topoisomerase II inhibitors on gastric cancer cells characterized by different genetic lesions 71
K-ras gene mutations: an unfavorable prognostic marker in stage I lung adenocarcinoma 66
Loss of heterozygosity and K-ras gene mutations in gastric cancer 62
Genetic events in sporadic colorectal adenomas; K-ras and p53 heterozygous mutations are not sufficient for malignant progression 60
Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients. 59
Primary retroperitoneal mucinous cystoadenocarcinomas: an immunohistochemical and molecular study 59
K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions 53
Heterogeneous protooncogene amplification correlates with tumor progression and presence of metastases in gastric cancer patients 52
Study on aneuploidy and p53 mutations in astrocytomas 51
The significance of p53 mutations in human cancers 48
Detection of K-ras mutations by denaturing gradient gel electrophoresis (DGGE): a study on pancreatic cancer 46
Gene amplification and proliferative kinetics in relation to prognosis of patients with gastric carcinoma 45
A 5'-truncated c-myc gene variant not associated with a risk of cancer 42
Base transitions are the most frequent genetic changes at P53 in gastric cancer 41
Aip-mutated acromegaly resistant to first-generation somatostatin analogs: Long-term control with pasireotide lar in two patients 39
Mutation of the Cell Cycle Regulator p27kip1 Drives Pseudohypoxic Pheochromocytoma Development 39
Combined Targeting of Pathogenetic Mechanisms in Pancreatic Neuroendocrine Tumors Elicits Synergistic Antitumor Effects 32
Adiponectin affects the mechanical responses in strips from the mouse gastric fundus 31
Characterization of neuroendocrine tumors in heterozygous mutant MENX rats: A novel model of invasive medullary thyroid carcinoma 30
Imaging pheochromocytoma in small animals: preclinical models to improve diagnosis and treatment 30
CDKN1B (p27) defects leading to pituitary tumors 29
The glucocorticoid receptor in brown adipocytes is dispensable for control of energy homeostasis 27
Animal models of MEN1 26
Multiple Endocrine Neoplasia Type 4 (MEN 4) 26
Adipocyte-specific tribbles pseudokinase 1 regulates plasma adiponectin and plasma lipids in mice 25
The norepinephrine transporter as a putative predictive biomarker for PI3K/mTOR inhibition in pheochromocytoma. 24
Obesity and cancer – extracellular matrix, angiogenesis, and adrenergic signaling as unusual suspects linking the two diseases 23
miR-34a is upregulated in AIP-mutated somatotropinomas and promotes octreotide resistance 20
Multiple Endocrine Neoplasia-Type 4 (MEN4) and Other MEN1-Like Syndromes 20
Editorial: Stem Cells in Endocrine Tumors 20
Gender-specific efficacy revealed by head-to-head comparison of pasireotide and octreotide in a representative in vivo model of nonfunctioning pituitary tumors 18
Angpt2/Tie2 autostimulatory loop controls tumorigenesis 17
Animal models of multiple endocrine neoplasia 16
Multiple Endocrine Neoplasia Type 4 13
Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures 12
Targeting PI3K/mTOR signaling exerts potent antitumor activity in pheochromocytoma in vivo 5
Animal and Cell Culture Models of PPGLs – Achievements and Limitations 5
Morphology, Biochemistry, and Pathophysiology of MENX-Related Pheochromocytoma Recapitulate the Clinical Features 3
Disclosing the CXCR4 Expression in Lymphoproliferative Diseases by Targeted Molecular Imaging 3
Aggressive tumor growth and clinical evolution in a patient with X-linked acro-gigantism syndrome 2
Ovarian hyperstimulation from ectopic hypersecretion of follicle stimulating hormone 2
Early onset acromegaly associated with a novel deletion in CDKN1B 5′UTR region 2
An AMP-activated protein kinase–stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in mice 2
SSTR3 is a putative target for the medical treatment of gonadotroph adenomas of the pituitary 2
X-linked acrogigantism syndrome: clinical profile and therapeutic responses 2
Obesity in MENX Rats Is Accompanied by High Circulating Levels of Ghrelin and Improved Insulin Sensitivity 2
Oncogenic features of the bone morphogenic protein 7 (BMP7) in pheochromocytoma 1
Identification of a Novel SSTR3 Full Agonist for the Treatment of Nonfunctioning Pituitary Adenomas 1
Multiple endocrine neoplasia type 4 (MEN4): a thorough update on the latest and least known men syndrome 1
Targeting PI3K/mTOR Signaling Displays Potent Antitumor Efficacy against Nonfunctioning Pituitary Adenomas 1
Preclinical evaluation of 18F-LMI1195 for in vivo imaging of pheochromocytoma in the MENX tumor model 1
Analysis of mammalian gene function through broad-based phenotypic screens across a consortium of mouse clinics 1
Responses to systemic therapy in metastatic pheochromocytoma/paraganglioma: a retrospective multicenter cohort study 1
Simultaneous magnetic resonance imaging of pH, perfusion and renal filtration using hyperpolarized 13C-labelled Z-OMPD 1
Primary Cell Culture Systems for Human Thyroid Studies 1
Inceptor correlates with markers of prostate cancer progression and modulates insulin/IGF1 signaling and cancer cell migration 1
Tribbles Genes in Gastric Cancer: A Tumor-Suppressive Role for TRIB2 1
Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas 1
Totale 1.386
Categoria #
all - tutte 6.383
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.383


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192 0 0 0 0 0 0 0 0 0 0 0 2
2019/2020203 63 83 0 10 0 10 0 13 0 14 10 0
2020/202195 10 8 3 10 0 13 8 13 3 12 12 3
2021/2022156 0 0 10 6 1 7 2 24 8 4 15 79
2022/2023550 44 47 4 31 63 59 2 31 246 3 12 8
2023/2024248 19 50 12 21 20 30 41 31 1 14 9 0
Totale 1.386